Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Agrarian is a private investment and company-building firm focused on modern food and agricultural technologies rather than human therapeutics. The firm invests in and helps develop companies in areas such as cellular agriculture, precision fermentation, alternative proteins, agtech, and related enabling technologies. Public descriptions indicate the business operates through investment and operational pillars, combining portfolio investing with hands-on development of selected companies and projects. It has also been involved in plans to develop a large-scale protein fermentation centre in Abu Dhabi to support manufacturing, commercialisation, and export of alternative proteins. While it operates in biotechnology-adjacent sectors, it is best characterized as a clean-food and food-tech investment platform, not a life sciences or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Agrarian.